Effect of hyperbaric oxygen therapy on peripheral blood inflammatory markers in patients with neuromyelitis optica spectrum disorder: a retrospective cohort study
HBOT may help rebalance the immune system in NMOSD by increasing lymphocyte counts and reducing NLR and PLR, potentially contributing to immune modulation. These findings support the potential of HBOT as an adjunctive therapy for NMOSD, particularly in patients with a high inflammatory burden. Larger prospective studies are warranted to confirm its long-term efficacy and underlying mechanisms.
Authors
- Shue‐Fen Luo (ORCID: https://orcid.org/0000-0001-6559-4434)
- Ying‐Qian Mo (ORCID: https://orcid.org/0000-0001-9617-8927)
- Liya Pan (ORCID: https://orcid.org/0009-0004-2980-8633)
- Yulan Wei
- Yuan Wu (ORCID: https://orcid.org/0000-0002-3282-1298)
Institutions
- Guangxi Medical University (CN)
- First Affiliated Hospital of GuangXi Medical University (CN)
- Fourth Affiliated Hospital of Guangxi Medical University (CN)
Publication Details
- Journal
- Frontiers in Neurology
- Published
- 2025-11-12
- DOI
- https://doi.org/10.3389/fneur.2025.1670455
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00